Prot# C1701-201: A Multicenter, Randomized, Double-Blind Placebo-controlled, Parallel-group, Single-dose, Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IW-1701 in Patients with Achalasia.

Project: Research project

StatusActive
Effective start/end date5/9/175/9/20

Funding

  • INC Research, LLC (Prot# C1701-201)
  • Ironwood Pharmaceuticals, Inc. (Prot# C1701-201)